In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats

Indian Journal of Pharmacology

Volumn 43, Issue 5, 2011, Pages 520-525

  Bihaqi, Syed Waseem ^a,b   Singh, Avninder Pal ^c   Tiwari, Manisha ^b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b UNIVERSITY OF DELHI   (India)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

Convolvulus pluricaulis; elevated plus maze; Morris water maze; oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT; BRAIN ENZYME; CONVOLVULUS PLURICAULIS EXTRACT; GLUTATHIONE; GLUTATHIONE REDUCTASE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; RIVASTIGMINE; SCOPOLAMINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CONVOLVULUS; CONVOLVULUS PLURICAULIS; ENZYME ACTIVITY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MAZE TEST; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; RAT; SPATIAL MEMORY;

EID: 80053379354     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.84958     Document Type: Article

References (27)

1. st ed., New Delhi: CBS Publishers 2000. p. 193-4.
2. Bhakuni RS, Tripathi AK, Shukla YN, Singh SC. Insect antifeedant constituent from Convolvulus microphyllus (L.) Sieb. Phytotherapy Res 1996;10:170-1.
3. Sinha SN, Dixit VP, Madnawat AVS, Sharma OP. The possible potentiation of cognitive processing on administration of Convolvulus microphyllus in rats. Indian Med 1989;1:1-6.
4. Singh RH, Mehta AK. Studies on the psychotropic effect of the Medhya Rasayana drug 'Shankapushpi' (Convolvulus Pluricaulis) Part 1 (Clinical Studies). J Res Indian Med Yoga Homeopathy 1977;12:18.
5. Bardgett ME, Henry JD. Locomotor activity and accumbens fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 1999;94:59-70.
6. Cutler NR, Polinsky RJ, Sramek JJ, Enz A, Jhee SS, Mancione L, et al. Dose-dependent CSF acetylcholine esterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurol Scand 1998;97:244-50.
7. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-3.
8. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press; 1982.
9. Ellman GL, Courtney KD, Andre V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholine esterase activity. Biochem Pharmacol 1961;7:88-95.
10. Rocha JB, Emanuelli T, Pereira ME. Effects of early under nutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp (Wars) 1993;53:431-7.
11. Tabor H, Mehler AH, Stadtman ER. The enzymatic acetylation of amines. J Biol Chem 1953;204:127-38.
12. Okhawa H, Ohishi N, Yaga K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
13. Reznick AZ, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
14. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114-21.
15. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975;25:5475-80.
16. Jollow DJ, Mitchell JR, Zampaglione N, Gillete JR. Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974;11:151-69.
17. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD (P)H oxidation. Methods Enzymol 1990;186: 209-20.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265-75.
19. Kopolman MD, Corn TH. Cholinergic "blockage" as a model of cholinergic depletion. Brain 1998;111:1079-110.
20. Mishima K, Tsukikawa H, Miura I, Inada K, Abe K, Matsumoto Y, et al. Ameliorative effect of NC-1900, a new AVP (4-9) analog, through vasopressin V (1A) receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacol 2003;44:541-52.
21. Rubaj A, Zgodzinski W, Sieklucka-Dziub M. The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine and MK-801-induced memory impairment. Behav Brain Res 2003;141:11-7.
22. Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, et al. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003;79:11-8.
23. Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T. Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 2004;78:787-91.
24. Gage FH, Bjorklund A. Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine-sensitive mechanism. J Neurosci 1986;6:2837-47.
25. Holschneider DP, Kumazawa T, Chen K, Shih JC. Tissue specific effects of estrogen on monoamine oxidase A and B in the rat. Life Sci 1998;63:155-60.
26. Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, et al. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. J Pharmacol Exp Ther 1997;280:710-20.
27. Chen L, Richardson JS, Caldwell JE, Ang LC. Regional brain activity of free radical defense enzyme in autopsy samples from patients with Alzheimer's disease and from non-demented controls. Int J Neurosci 1994;75:83-90.